The introduction of retatrutide, a promising medication for weight management, has naturally sparked significant discussion regarding its expense. Currently, there is publicly released information regarding the final retail value of retatrutide. However, analysts estimate that it will likely be in line with other modern GLP-1 receptor agonists like